Compare MBIN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBIN | PLSE |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2017 | 2016 |
| Metric | MBIN | PLSE |
|---|---|---|
| Price | $36.36 | $14.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $39.67 | $22.00 |
| AVG Volume (30 Days) | 164.8K | ★ 182.7K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | ★ $597,247,000.00 | $86,000.00 |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $8.80 | $1,002.94 |
| P/E Ratio | $8.34 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.25 | $12.56 |
| 52 Week High | $43.82 | $25.00 |
| Indicator | MBIN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 71.07 | 49.44 |
| Support Level | $36.17 | $13.94 |
| Resistance Level | $37.36 | $14.70 |
| Average True Range (ATR) | 0.92 | 0.64 |
| MACD | 0.22 | 0.22 |
| Stochastic Oscillator | 80.99 | 68.61 |
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.